HCA Healthcare Inc (HCA)
Sous-évaluéFondamental
81
Prix
$426.74
Capitalisation boursière
$95.97B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 septembre 2026 with claude-haiku-4-5 — shared with all users
The closest for-profit peer to HCA: Tenet runs acute care hospitals and a large ambulatory surgery platform in many of the same Sun Belt metro markets, competing for the same patients, the same physicians and the same commercial insurance contracts.
Operates general acute care hospitals alongside the largest US network of behavioral health facilities, overlapping with HCA's hospitals in states such as Nevada, Texas and Florida for the same inpatient admissions and payer contracts.
A for-profit chain of acute care hospitals concentrated in smaller cities and suburban markets across the South and Midwest, competing with HCA for community hospital volumes and for physician recruitment in overlapping states.
Runs about 30 acute care hospitals and roughly 280 sites of care in mid-sized urban markets in Texas, Oklahoma, New Mexico, Kansas, Idaho and New Jersey, several of which overlap directly with HCA's hospital networks.
One of the largest non-profit hospital systems in the United States, with facilities in Tennessee, Texas and Florida that draw the same patients as HCA's hospitals; HCA's own 10-K singles out such tax-exempt systems as its competition.
A non-profit system of more than 140 hospitals born from the Dignity Health–CHI merger, competing with HCA for inpatient and outpatient volumes in Texas, Colorado, Nevada and California.
Bilan & Liquidités
Chiffre d'affaires
$76.39B
12 derniers mois (au 31/03/2026)
Résultat net
$6.79B
12 derniers mois (au 31/03/2026)
Flux de trésorerie libre
$7.69B
Capitaux propres totaux
$-6.03B
Passif total
$63.49B
Ratio de liquidité général
0.83
Couverture des intérêts
-
Dette/EBITDA
3.17
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$685.77
Prix actuel
$426.74
Marge de sécurité
+37.8%
Fourchette de juste valeur
$445.75 - $925.79
Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
14.70
ROE
-112.6%
Ratio P/B
-
P/FCF
11.94
Marge brute
-
ROIC
-
Radar de rentabilité
Création de valeur (avantage concurrentiel)
ROIC
-
WACC
8.3%
ROIC − WACC
-
Critères d'analyse fondamentale
Réussi (18)
- EPS shows upward trend
- EPS CAGR 16.56%
- Price CAGR 19.15%
- P/FCF 11.94
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 695.7%
- Revenue Growth 5Y 8.0%
- Analyst Consensus 57% Buy
- Earnings Surprise avg 7.2%
- PEG Ratio 0.65
- Earnings Quality (OCF/NI) 1.91
- Share Dilution -8.5%
- Net Margin Trend 8.9% vs 8.1%
- Piotroski F-Score 6/9
Échoué (2)
- CapEx intensity
- DCF valuation (Overvalued)
Indisponible (8)
- ROIC NaN%
- Gross Margin NaN%
- P/B Ratio NaN
- Dividend Payout NaN%
- Debt/Equity ratio
- Operating Margin NaN%
- Interest Coverage
- Price below Graham Number
Score F de Piotroski
Signaux mixtes : certains domaines nécessitent attention
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Participations institutionnelles
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Mr. Samuel N. Hazen | CEO & Director | 65 |
| Mr. Michael A. Marks | CFO & Executive VP | 55 |
| Mr. Jon Mack Foster | Executive VP & COO | 63 |
| Mr. Michael R. McAlevey | Executive VP and Chief Legal & Administrative Officer | 61 |
| Dr. Michael S. Cuffe M.B.A., M.D. | Executive Officer | 59 |
| Dr. Thomas F. Frist Jr., M.D. | Founder & Chairman Emeritus | 86 |
| Mr. Christopher F. Wyatt | Senior VP, Principal Accounting Officer & Controller | 47 |
| Mr. Chad J. Wasserman | Senior VP & Chief Information Officer | - |
| Mr. Frank George Morgan C.F.A. | Vice President of Investor Relations | - |
| Ms. Wendy Warren | Senior VP and Chief Ethics & Compliance Officer | - |
Risque d'audit
8
Risque du conseil
9
Risque de rémunération
4
Risque droits des actionnaires
3
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Documents
- Voir le document
Rapport annuel (10-K)
Un aperçu annuel de l'activité, des résultats financiers et des risques de l'entreprise.
Déposé le 2026-02-10
- Voir le document
Rapport trimestriel (10-Q)
Une mise à jour de la performance financière des trois derniers mois.
Déposé le 2026-07-28
- Voir le document
Rapport d'événement important (8-K)
Un avis concernant un événement important, comme un changement de direction ou une annonce majeure.
Déposé le 2026-07-29
via SEC EDGAR
Historique des résultats
via SEC EDGAR
Latest News
Recent headlines for HCA, sourced from Markets Gazette.
- 6/15/2026NEUTRALHere's How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 Years
An analysis of HCA Healthcare Inc. stock reveals its performance over the past 15 years. While the article title suggests a focus on potential returns for investors, the content itself is not provided, making it impossible to ascertain specific financial metrics, growth drivers, or any recent developments. Therefore, without detailed information on earnings, strategic initiatives, or market positioning, a definitive assessment of its current investment appeal or future outlook cannot be made. The historical performance, while potentially positive, does not offer actionable insights for present trading decisions.
- 4/24/2026NEUTRALHCA Healthcare Q1 2026 Earnings Call Transcript
HCA Healthcare is scheduled to hold its Q1 2026 Earnings Call on April 24, 2026. While the transcript is available, the provided information does not contain the actual earnings results, forward-looking guidance, or any specific operational updates that would allow for an assessment of financial performance or market impact. Investors should consult the full transcript or subsequent reports for detailed financial figures, management commentary on performance drivers, and future outlook.
- 4/24/2026POSITIVEHCA Healthcare Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
HCA Healthcare is poised to report its Q1 earnings on April 24th, with analysts projecting earnings per share of $7.15, a notable increase from $6.45 in the prior year. This upward revision in forecasts by analysts, who are recognized for their accuracy, suggests a positive outlook for the company's performance. The stock's modest 0.6% gain on Thursday further indicates investor optimism ahead of the earnings call. For investors, this anticipated earnings growth and analyst confidence signal potential for continued stock appreciation.
- 4/23/2026NEUTRALHow To Earn $500 A Month From HCA Healthcare Stock Ahead Of Q1 Earnings
HCA Healthcare offers an annual dividend yield of 0.66%, equating to $3.12 per share annually. The article explores strategies for investors to generate approximately $500 per month from this dividend, suggesting a focus on dividend reinvestment or accumulation strategies. While the dividend itself is a positive attribute for income-focused investors, the news primarily focuses on a strategy for income generation rather than a direct catalyst for stock price appreciation ahead of Q1 earnings. The actual Q1 earnings results, which are not yet released, will be the primary driver of short-term stock movement.
- 2/26/2026POSITIVEHere's How Much $1000 Invested In HCA Healthcare 15 Years Ago Would Be Worth Today
A retrospective analysis of an investment in HCA Healthcare reveals exceptional performance for long-term shareholders. An initial $1,000 investment made 15 years ago would today be worth a significantly larger sum, underscoring the robust and consistent growth of the healthcare sector and, specifically, this leading company. HCA Healthcare's ability to generate value over time, navigating economic cycles and market challenges, highlights its resilience and the strength of its business model. This data not only celebrates past success but also offers insights into the potential of strategic, long-term investments in defensive sectors and companies with solid fundamentals.
via Markets Gazette